![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV SPRINT-1: Final Results SVR 24 NS3 Protease Inhibitor Boceprevir plus PegIFN alpha-2b/Ribavirin HCV 1 Treatment Naïve Patients
|
|
|
EASL
April 23, 2009
Copenhagen, Denmark
Reported by Jules Levin
Paul Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff,
John M Vierling, David Pound, Mitchell Davis, Joseph S Galati,
Stuart C Gordon, Natarajan Ravendhran, Lorenzo Rossaro,
Frank H Anderson, Ira M Jacobson, Raymond Rubin,
Kenneth Koury, Lisa Pedicone, Eirum Chaudhri, and Janice K Albrecht
![Amis-1.gif](../images/043009/Amis-1.gif)
![summary-2.gif](../images/043009/summary-2.gif)
![sprint-3.gif](../images/043009/sprint-3.gif)
![part-4.gif](../images/043009/part-4.gif)
![part1-5.gif](../images/043009/part1-5.gif)
![rvr-6.gif](../images/043009/rvr-6.gif)
![COBAS-7.gif](../images/043009/COBAS-7.gif)
![Durartion-8.gif](../images/043009/Durartion-8.gif)
![missing-9.gif](../images/043009/missing-9.gif)
![nadir-10.gif](../images/043009/nadir-10.gif)
![control-11.gif](../images/043009/control-11.gif)
![upon-12.gif](../images/043009/upon-12.gif)
![sprint-13.gif](../images/043009/sprint-13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|